Glycans in Vaccine Development
Glycans are at the center of many disorders and diseases sparking the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycans are intricately involved. Gaging the vast potential and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.
- Glycoconjugate vaccines
- Glycoengineering of immunogens
- Biomarkers in drug design
- Screening and drug design
- Drug interaction in cellular networking
- Biodefense vaccine mechanism
Related Conference of Glycans in Vaccine Development
October 13-14, 2025
17th International Conference on Tissue Science and Regenerative Medicine
Rome, Italy
Glycans in Vaccine Development Conference Speakers
Recommended Sessions
- Cancer Biology and Structural Biology
- Genomics and Metabolomics
- Glycans in Diseases and Therapeutics
- Glycans in Structural and Computational Systems Biology
- Glycans in Vaccine Development
- Glycobiology and Glycochemistry
- Glycobiology in Lipid Science
- Glycoconjugates, Glycomics and Transcriptomics
- Glycosciences and Monosaccharides
- Mass Spectrometry Analysis
- Structural Bioinformatics and Proteomics